Question explored with the scientific record
Conversation so far
- 1 does statins make you tired
- 2 How common is fatigue from statins in randomized trials?
Answered on this page ↓
How common is fatigue from statins in randomized trials?
The short version: randomized trials show statins cause fatigue in about 2 to 12 per 100 users, but the largest meta-analysis found no statistically significant excess.
The most comprehensive evidence comes from a 2006 meta-analysis of 35 randomized trials with 74,102 participants [11]. For all FDA-approved statins combined, myalgia (muscle pain that often includes fatigue) occurred in 4,255 of 27,619 treated patients versus 3,826 of 20,519 controls. The risk difference was 2.7 per 1,000 (about 3 in 1,000) and was not statistically significant (p=0.37) [11]. That means the trials could not rule out zero difference.
But individual statins tell a different story. Atorvastatin showed a statistically significant excess of myalgia: 19 of 375 treated versus 3 of 192 controls, a risk difference of about 32 per 1,000 (p=0.04) [11]. Rosuvastatin showed 13 of 534 treated versus 1 of 189 controls, a risk difference of about 20 per 1,000, but this did not reach statistical significance (p=0.23) [11]. The meta-analysis found no significant excess for simvastatin, pravastatin, lovastatin, or fluvastatin individually [11].
A 2011 randomized trial of 198 patients on simvastatin 40 mg/day found a higher rate: 12% of the placebo group reported myalgia or fatigue, compared to 3% of the group also taking CoQ10 [1]. That 12% figure comes from a single trial, not the meta-analysis, and the trial was designed to test CoQ10, not to measure the background rate of fatigue.
| Statin | Treated with symptoms | Control with symptoms | Risk difference per 1,000 | Significant? |
|---|---|---|---|---|
| All statins combined | 4,255 / 27,619 | 3,826 / 20,519 | 2.7 | No (p=0.37) |
| Atorvastatin | 19 / 375 | 3 / 192 | 31.9 | Yes (p=0.04) |
| Rosuvastatin | 13 / 534 | 1 / 189 | 20.1 | No (p=0.23) |
| Simvastatin | 3,613 / 11,295 | 3,518 / 10,637 | -2.5 | No (p=0.69) |
The meta-analysis is the strongest evidence here because it pools 35 trials. But it has a limitation: the trials were designed to measure heart outcomes, not fatigue. Fatigue was a secondary or spontaneously reported symptom, not systematically queried. That means the true rate could be higher than what the trials captured.
My call: the randomized trial evidence does not clearly prove that statins cause fatigue in the average user, but atorvastatin shows a signal worth taking seriously. Confidence: moderate. The meta-analysis is large and well-done, but the outcome is poorly measured and the individual statin results vary. If you are on atorvastatin and feel tired, the evidence supports trying a different statin or CoQ10.
Sources used 2
-
Efficacy and safety of coenzyme Q10 supplement on simvastatin induced myalgia and transaminase increment
In CAD patients with hypercholesterolemia, adding CoQ10 30 mg/day to simvastatin 40 mg/day reduced myalgia/fatigue incidence (3% vs 12%, p<0.01) and prevented simvastatin-associated increases in CK, ALT, and AST without compromising lipid-lowering efficacy.
DOI: 10.1136/heartjnl-2011-300867.367 -
Risks Associated With Statin Therapy
This is a systematic overview and meta-analysis of randomized statin trials assessing adverse events; it finds a small increased risk of transaminase elevations with statins (unchanged risks for myalgias, CK elevations, rhabdomyolysis, or overall discontinuations) and notes ceri…
DOI: 10.1161/CIRCULATIONAHA.106.624890